INDAPAMIDE Drug Patent Profile
✉ Email this page to a colleague
When do Indapamide patents expire, and when can generic versions of Indapamide launch?
Indapamide is a drug marketed by Actavis Elizabeth, Ani Pharms, Aurobindo Pharma Usa, Chartwell Rx, Rising, Teva, and Watson Labs. and is included in nine NDAs.
The generic ingredient in INDAPAMIDE is indapamide. There are seven drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the indapamide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Indapamide
A generic version of INDAPAMIDE was approved as indapamide by ANI PHARMS on July 27th, 1995.
Summary for INDAPAMIDE
US Patents: | 0 |
Applicants: | 7 |
NDAs: | 9 |
Finished Product Suppliers / Packagers: | 6 |
Raw Ingredient (Bulk) Api Vendors: | 114 |
Clinical Trials: | 31 |
Patent Applications: | 4,665 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for INDAPAMIDE |
DailyMed Link: | INDAPAMIDE at DailyMed |
Recent Clinical Trials for INDAPAMIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Centre for Chronic Disease Control, India | Phase 4 |
All India Institute of Medical Sciences, New Delhi | Phase 4 |
The Third Xiangya Hospital of Central South University | Phase 4 |
Pharmacology for INDAPAMIDE
Drug Class | Thiazide-like Diuretic |
Physiological Effect | Increased Diuresis |
Medical Subject Heading (MeSH) Categories for INDAPAMIDE
Anatomical Therapeutic Chemical (ATC) Classes for INDAPAMIDE
US Patents and Regulatory Information for INDAPAMIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Actavis Elizabeth | INDAPAMIDE | indapamide | TABLET;ORAL | 074722-001 | Jun 17, 1996 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Watson Labs | INDAPAMIDE | indapamide | TABLET;ORAL | 074585-002 | Sep 26, 1996 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Ani Pharms | INDAPAMIDE | indapamide | TABLET;ORAL | 074498-001 | Oct 31, 1996 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Ani Pharms | INDAPAMIDE | indapamide | TABLET;ORAL | 074498-002 | Feb 12, 1998 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Chartwell Rx | INDAPAMIDE | indapamide | TABLET;ORAL | 074594-002 | May 23, 1996 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |